Kossel and InnoMed Enter Strategic Partnership for Global Commercialization of Python DCB
Exclusive overseas distribution plus technical cooperation advances Kossel’s peripheral DCB value chain roadmap Suzhou, China — Kossel Medtech (Suzhou) Co., Ltd. (“Kossel”) has entered into a strategic cooperation agreement with InnoMed Technology Limited (“InnoMed”). Pursuant to the strategic cooperation agreement, Kossel is granted exclusive overseas distribution rights for InnoMed’s Python Drug-Eluting Dilatation Catheter. Drawing on its established commercial footprint […]
Key Milestone: Kossel’s Overseas Peripheral Portfolio Accelerates Global Expansion via EU CE‑MDR Certification
Kossel is pleased to announce a major regulatory milestone. Its peripheral interventional device portfolio has obtained EU CE‑MDR certification, granting official European market access and marking a key step in the company’s global expansion. All four newly‑certified devices are independently developed in‑house by Kossel: Falspeed® PTA Balloon Dilatation Catheter, Falexpand® HP PTA Balloon Dilatation Catheter, […]
SOLACI & SBHCI 2026 Concludes Successfully; Kossel Expands Partnership Footprint Across South America
Held in São Paulo, Brazil from July 29 to 31, 2026, SOLACI & SBHCI 2026 stands as the flagship annual event for cardiovascular intervention across Latin America. The conference brought together leading global specialists in panvascular intervention, clinicians and industry distributors. Through academic forums, hands-on training sessions and product exhibitions, participants explored new pathways for […]
Kossel Makes a Stunning Debut on the Global Medical Stage — A Successful Wrap-up of CVIT 2026!
From July 16 to 18, 2026, the 34th Annual Meeting of the Japanese Cardiovascular Intervention Therapeutics (CVIT 2026) was successfully held at Tokyo International Forum. The conference brought together top clinical specialists, researchers and leading industry players worldwide to discuss cutting-edge advances and future trends in minimally invasive interventional diagnosis and treatment. With years of […]
Good News | Expanding Footprint in Southeast Asia: Selethru® PTCA Balloon Dilatation Catheter Secures Singapore Registration Approval
Recently, Selethru® PTCA Balloon Dilatation Catheter, independently developed by Kossel Medtech, has obtained official marketing approval from Singapore’s Health Sciences Authority (HSA). This milestone further optimizes the Company’s strategic layout across Southeast Asia and accelerates its global expansion drive. As a hub for medical innovation in Southeast Asia, Singapore boasts world-leading medical regulatory frameworks and […]
Good News | Expanding Footprint in Southeast Asia: Selethru® PTCA Balloon Dilatation Catheter Secures Singapore Registration Approval
Recently, Selethru® PTCA Balloon Dilatation Catheter, independently developed by Kossel Medtech, has obtained official marketing approval from Singapore’s Health Sciences Authority (HSA). This milestone further optimizes the Company’s strategic layout across Southeast Asia and accelerates its global expansion drive. As a hub for medical innovation in Southeast Asia, Singapore boasts world-leading medical regulatory frameworks and […]
Good News | Two Peripheral Balloon Catheters Obtain Hong Kong SAR Registration Certificates, Kossel Medtech Accelerates Global Layout
Recently, Falspeed® PTA Balloon Dilatation Catheter and Falexpand® HP PTA Balloon Dilatation Catheter, two independently developed products by Kossel Medtech, have officially secured registration certification from the Department of Health of the Hong Kong Special Administrative Region (HKSAR), granting approval for marketing and sales in Hong Kong. As an Asian hub for medical innovation and […]
Good News | K-VisionMax™ Peripheral IVUS System Approved for Market Launch, Empowering Precision Diagnosis and Treatment!
Previously, Kossel Medtech (Suzhou) Co., Ltd. (hereinafter referred to as “Kossel Medtech”) completed the strategic acquisition of the peripheral vascular intervention business of Shanghai Biotriton Medical Technology Co., Ltd (hereinafter referred to as “Biotriton Medical”), further strengthening Kossel Medtech’s comprehensive one-stop diagnosis and treatment portfolio in the peripheral intervention field. Recently, Biotriton Medical’s independently developed […]
Good News | MiStent® Coronary Drug-Eluting Stent Approved, Offering a New Clinical Option for PCI!
Recently, MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System, the flagship product of Mixin Medtech, a subsidiary of Kossel Group, has been successfully approved for market launch by the National Medical Products Administration (NMPA) (Registration Certificate No.: GXZZ 20263130833). MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System was developed following Kossel Group’s complete acquisition of […]
Congratulations | Kossel and Medtronic Create a New Future for Precise Coronary Intervention
January 20, 2026 – The strategic cooperation signing ceremony between Kossel Medtech (Suzhou) Co., Ltd (“Kossel”) and Medtronic (Shanghai) Management Co., Ltd. (“Medtronic”) was successfully held. This collaboration marks the establishment of a deep strategic partnership. Centered on Kossel’s core product, the Seledora® Coronary Scoring Balloon Catheter, the two sides will work together to promote its […]